credits

Education

Page 5 of 5

Results 301 - 326 of 326

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Radiologic Features of IPF

A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT

32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...

A 60 y/o Male w/4-year History Of Shoulder Weakness

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Individualizing Patient Education in Treatment Choice: Practical Strategies

Addressing Common Barriers to Adherence

Approach to Genetic Testing in Myopathies

Molecular Diagnosis of Limb-Girdle Muscle Weakness

Page 5 of 5